Skip to main content
Schrödinger, Inc. (SDGR)
NASDAQ: SDGR · Real-Time Price · USD
19.84
+0.99 (5.25%)
At close: Aug 13, 2025, 4:00 PM
20.00
+0.16 (0.81%)
After-hours: Aug 13, 2025, 7:31 PM EDT

Schrödinger Software Products and Services Revenue Breakdown
Period Ending Mar 31, 2025Mar 31, 2025Mar 31, 2025Dec 31, 2024Dec 31, 2024Dec 31, 2024Sep 30, 2024Sep 30, 2024Sep 30, 2024Jun 30, 2024Jun 30, 2024Jun 30, 2024Mar 31, 2024Mar 31, 2024Mar 31, 2024Dec 31, 2023Dec 31, 2023Dec 31, 2023Sep 30, 2023Sep 30, 2023Sep 30, 2023Jun 30, 2023Jun 30, 2023Jun 30, 2023Mar 31, 2023Mar 31, 2023Mar 31, 2023Dec 31, 2022Dec 31, 2022Dec 31, 2022Sep 30, 2022Sep 30, 2022Sep 30, 2022Jun 30, 2022Jun 30, 2022Jun 30, 2022
Software Products and Services
26.27M 26.27M 26.27M 23.32M 23.32M 23.32M 22.81M 22.81M 22.81M
Software Products and Services
26.27M 26.27M 26.27M 23.32M 23.32M 23.32M 22.81M 22.81M 22.81M
Software Contribution
13.66M 13.66M 13.66M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Software Products and Services Growth
13.80% 13.80% 13.80% 1.39% 1.39% 1.39% -2.80% -2.80% -2.80%
Drug Discovery
7.96M 7.96M 7.96M 8.98M 8.98M 8.98M 8.83M 8.83M 8.83M
Drug Discovery
7.96M 7.96M 7.96M 8.98M 8.98M 8.98M 8.83M 8.83M 8.83M
Drug Discovery Growth
-8.59% -8.59% -8.59% -5.58% -5.58% -5.58% -18.87% -18.87% -18.87%

Revenue by Type
Period Ending Mar 31, 2025Mar 31, 2025Mar 31, 2025Dec 31, 2024Dec 31, 2024Dec 31, 2024Sep 30, 2024Sep 30, 2024Sep 30, 2024Jun 30, 2024Jun 30, 2024Jun 30, 2024Mar 31, 2024Mar 31, 2024Mar 31, 2024Dec 31, 2023Dec 31, 2023Dec 31, 2023Sep 30, 2023Sep 30, 2023Sep 30, 2023Jun 30, 2023Jun 30, 2023Jun 30, 2023Mar 31, 2023Mar 31, 2023Mar 31, 2023Dec 31, 2022Dec 31, 2022Dec 31, 2022
Software Products and Services
195.80M 195.80M 195.80M 180.40M 180.40M 180.40M 169.40M 169.40M 169.40M 166.42M 166.42M 166.42M 160.37M 160.37M 160.37M 159.17M 159.17M 159.17M 138.27M 138.27M 138.27M 134.03M 134.03M 134.03M
Software Products and Services Growth
22.09% 22.09% 22.09% 13.34% 13.34% 13.34% 22.52% 22.52% 22.52% 24.17% 24.17% 24.17% 19.07% 19.07% 19.07% 17.42% 17.42% 17.42% - - - - - -
Drug Discovery
34.77M 34.77M 34.77M 27.22M 27.22M 27.22M 24.02M 24.02M 24.02M 34.28M 34.28M 34.28M 28.19M 28.19M 28.19M 57.57M 57.57M 57.57M 61.07M 61.07M 61.07M 59.72M 59.72M 59.72M
Drug Discovery Growth
23.37% 23.37% 23.37% -52.72% -52.72% -52.72% -60.67% -60.67% -60.67% -42.60% -42.60% -42.60% -54.79% -54.79% -54.79% 26.94% 26.94% 26.94% - - - - - -

Drug Discovery Revenue Breakdown
Period Ending Mar 31, 2025Mar 31, 2025Mar 31, 2025Dec 31, 2024Dec 31, 2024Dec 31, 2024Sep 30, 2024Sep 30, 2024Sep 30, 2024Jun 30, 2024Jun 30, 2024Jun 30, 2024Mar 31, 2024Mar 31, 2024Mar 31, 2024Dec 31, 2023Dec 31, 2023Dec 31, 2023Sep 30, 2023Sep 30, 2023Sep 30, 2023Jun 30, 2023Jun 30, 2023Jun 30, 2023Mar 31, 2023Mar 31, 2023Mar 31, 2023Dec 31, 2022Dec 31, 2022Dec 31, 2022
Drug Discovery Services Customer Contracts
32.69M 32.69M 32.69M 25.14M 25.14M 25.14M 21.97M 21.97M 21.97M 31.88M 31.88M 31.88M 25.61M 25.61M 25.61M 54.72M 54.72M 54.72M 58.22M 58.22M 58.22M 57.20M 57.20M 57.20M
Drug Discovery Services Customer Contracts Growth
27.64% 27.64% 27.64% -54.05% -54.05% -54.05% -62.27% -62.27% -62.27% -44.26% -44.26% -44.26% -57.31% -57.31% -57.31% 26.00% 26.00% 26.00% - - - - - -
Drug Discovery Contribution
2.04M 2.04M 2.04M 2.03M 2.03M 2.03M 2.02M 2.02M 2.02M 2.37M 2.37M 2.37M 2.55M 2.55M 2.55M 2.82M 2.82M 2.82M 2.88M 2.88M 2.88M 2.54M 2.54M 2.54M
Drug Discovery Contribution Growth
-19.95% -19.95% -19.95% -28.03% -28.03% -28.03% -29.72% -29.72% -29.72% -6.89% -6.89% -6.89% 7.24% 7.24% 7.24% 44.72% 44.72% 44.72% - - - - - -

Revenue by Geography
Period Ending Mar 31, 2025Mar 31, 2025Mar 31, 2025Dec 31, 2024Dec 31, 2024Dec 31, 2024Sep 30, 2024Sep 30, 2024Sep 30, 2024Jun 30, 2024Jun 30, 2024Jun 30, 2024Mar 31, 2024Mar 31, 2024Mar 31, 2024Dec 31, 2023Dec 31, 2023Dec 31, 2023Sep 30, 2023Sep 30, 2023Sep 30, 2023Jun 30, 2023Jun 30, 2023Jun 30, 2023Mar 31, 2023Mar 31, 2023Mar 31, 2023Dec 31, 2022Dec 31, 2022Dec 31, 2022
United States
121.24M 121.24M 121.24M 114.87M 114.87M 114.87M 133.14M 133.14M 133.14M 141.65M 141.65M 141.65M 134.91M 134.91M 134.91M 161.96M 161.96M 161.96M 146.14M 146.14M 146.14M 140.49M 140.49M 140.49M
United States Growth
-10.14% -10.14% -10.14% -29.08% -29.08% -29.08% -8.89% -8.89% -8.89% 0.83% 0.83% 0.83% -6.07% -6.07% -6.07% 31.08% 31.08% 31.08% - - - - - -
EMEA
81.54M 81.54M 81.54M 65.65M 65.65M 65.65M 33.86M 33.86M 33.86M 32.48M 32.48M 32.48M 29.50M 29.50M 29.50M 29.14M 29.14M 29.14M 27.69M 27.69M 27.69M 28.36M 28.36M 28.36M
EMEA Growth
176.37% 176.37% 176.37% 125.33% 125.33% 125.33% 22.28% 22.28% 22.28% 14.51% 14.51% 14.51% 3.03% 3.03% 3.03% -15.43% -15.43% -15.43% - - - - - -
APAC
26.38M 26.38M 26.38M 25.80M 25.80M 25.80M 25.18M 25.18M 25.18M 25.47M 25.47M 25.47M 23.00M 23.00M 23.00M 24.57M 24.57M 24.57M 31.14M 31.14M 31.14M 30.47M 30.47M 30.47M
APAC Growth
14.69% 14.69% 14.69% 5.02% 5.02% 5.02% -19.14% -19.14% -19.14% -16.40% -16.40% -16.40% -15.44% -15.44% -15.44% 13.33% 13.33% 13.33% - - - - - -
Rest of World
1.35M 1.35M 1.35M 1.22M 1.22M 1.22M 1.16M 1.16M 1.16M 1.03M 1.03M 1.03M 1.07M 1.07M 1.07M 1.00M 1.00M 1.00M -5.59M -5.59M -5.59M -5.52M -5.52M -5.52M
Rest of World Growth
25.94% 25.94% 25.94% 21.68% 21.68% 21.68% - - - - - - - - - -21.06% -21.06% -21.06% - - - - - -
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.